サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：口蹄疫（FMD）ワクチンの世界市場－成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1176508

口蹄疫（FMD）ワクチンの世界市場－成長、将来展望、競合分析（2022年～2030年）

Foot And Mouth Disease (FMD) Vaccines Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
口蹄疫（FMD）ワクチンの世界市場－成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月02日
発行: Acute Market Reports
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の口蹄疫（FMD）ワクチンの市場規模は、2022年から2030年の予測期間中に8.1％のCAGRで成長し、38億8,607万米ドルに達すると予想されています。口蹄疫の発生を防止・制限するための政府の積極的な取り組み、米国・カナダ・英国などの先進国での予防接種プログラムの増加は、市場の成長を促進しています。

当レポートでは、世界の口蹄疫（FMD）ワクチン市場について調査分析し、競合分析、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
    • レポートの目的
    • 対象者
    • 主な製品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ－2次調査
    • フェーズⅡ－1次調査
    • フェーズⅢ－専門家による審査
    • 仮定
    • 採用されたアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の口蹄疫（FMD）ワクチン市場
  • 世界の口蹄疫（FMD）ワクチン市場（100万米ドル）（2021年）：ワクチン別
  • 世界の口蹄疫（FMD）ワクチン市場（100万米ドル）（2021年）：動物別
  • 世界の口蹄疫（FMD）ワクチン市場（100万米ドル）（2021年）：地域別
  • 魅力的な投資提案（2021年）：地域別

第3章 口蹄疫（FMD）ワクチン市場：競合分析

  • 主要な口蹄疫（FMD）ワクチン市場ベンダーの市場ポジショニング
  • 口蹄疫（FMD）ワクチン市場のベンダーが採用する戦略
  • 主要な業界戦略
  • 階層分析：2021年と2030年の比較

第4章 口蹄疫（FMD）ワクチン市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の口蹄疫（FMD）ワクチンの市場金額（100万米ドル）（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 口蹄疫（FMD）ワクチン市場、米ドル（100万）（2020年～2030年）：ワクチン別

  • 市場概要
  • 成長と収益分析：2021年と2030年の比較
  • 市場セグメンテーション
    • 従来ワクチン
    • 緊急ワクチン

第6章 口蹄疫（FMD）ワクチン市場、米ドル（100万）（2020年～2030年）：動物別

  • 市場概要
  • 成長と収益分析：2021年と2030年の比較
  • 市場セグメンテーション
    • 牛
    • 羊とヤギ
    • 豚
    • その他（シカ、カモシカ、ガゼル）

第7章 北米の口蹄疫（FMD）ワクチン市場、米ドル（100万）（2020年～2030年）

第8章 英国および欧州連合の口蹄疫（FMD）ワクチン市場、米ドル（100万）（2020年～2030年）

第9章 アジア太平洋の口蹄疫（FMD）ワクチン市場、米ドル（100万）（2020年～2030年）

第10章 ラテンアメリカの口蹄疫（FMD）ワクチン市場、米ドル（100万）（2020年～2030年）

第11章 中東およびアフリカの口蹄疫（FMD）ワクチン市場、米ドル（100万）（2020年～2030年）

第12章 企業プロファイル

  • India Immunological Ltd.
  • Merck Animal Health
  • Brilliant Bio Pharma Ltd.
  • Agrovet Co.
  • Merial S.A.S
  • Inova Biotecnologia
  • Intervac（Pvt）. Ltd.
  • China Animal Husbandry Co., Ltd.
  • Biogenesis-Bago S.A.
  • Vetal Animal Health Products S.A.
図表

List of Tables

  • TABLE 1 Global Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 2 Global Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 3 Global Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 4 North America Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 5 North America Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 6 North America Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 7 U.S. Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 8 U.S. Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 9 U.S. Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 10 Canada Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 11 Canada Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 12 Canada Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 13 Rest of North America Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 14 Rest of North America Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 15 Rest of North America Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 16 UK and European Union Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 17 UK and European Union Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 18 UK and European Union Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 19 UK Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 20 UK Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 21 UK Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 22 Germany Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 23 Germany Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 24 Germany Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 25 Spain Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 26 Spain Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 27 Spain Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 28 Italy Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 29 Italy Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 30 Italy Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 31 France Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 32 France Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 33 France Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 34 Rest of Europe Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 35 Rest of Europe Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 36 Rest of Europe Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 37 Asia Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 38 Asia Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 39 Asia Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 40 China Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 41 China Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 42 China Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 43 Japan Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 44 Japan Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 45 Japan Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 46 India Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 47 India Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 48 India Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 49 Australia Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 50 Australia Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 51 Australia Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 52 South Korea Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 53 South Korea Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 54 South Korea Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 55 Latin America Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 56 Latin America Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 57 Latin America Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 58 Brazil Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 59 Brazil Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 60 Brazil Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 61 Mexico Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 62 Mexico Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 63 Mexico Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 64 Rest of Latin America Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 65 Rest of Latin America Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 66 Rest of Latin America Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 67 Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 68 Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 69 Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 70 GCC Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 71 GCC Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 72 GCC Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 73 Africa Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 74 Africa Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 75 Africa Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market By Vaccine, 2020-2030, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market By Conventional Vaccines, 2020-2030, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market By Animal, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Foot And Mouth Disease (FMD) Vaccines Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Foot And Mouth Disease (FMD) Vaccines Market: Quality Assurance
  • FIG. 5 Global Foot And Mouth Disease (FMD) Vaccines Market, By Vaccine, 2021
  • FIG. 6 Global Foot And Mouth Disease (FMD) Vaccines Market, By Animal, 2021
  • FIG. 7 Global Foot And Mouth Disease (FMD) Vaccines Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Foot And Mouth Disease (FMD) Vaccines Market, 2021
  • FIG. 9 Market Positioning of Key Foot And Mouth Disease (FMD) Vaccines Market Players, 2021
  • FIG. 10 Global Foot And Mouth Disease (FMD) Vaccines Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Foot And Mouth Disease (FMD) Vaccines Market, By Vaccine, 2021 Vs 2030, %
  • FIG. 12 Global Foot And Mouth Disease (FMD) Vaccines Market, By Animal, 2021 Vs 2030, %
  • FIG. 13 U.S. Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 20 France Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 22 China Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 24 India Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market (US$ Million), 2020 - 2030
目次
Product Code: 138285-08-22

Industry Outlook

The global foot and mouth disease (FMD) vaccines market to reach US$ 3,886.07 Mn in 2030 and projected to exhibit a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2022 to 2030. FMD is highly contagious viral disease and sometimes fatal affecting cloven hoofed animals that includes domestic and wild bovids. Control and prevention of FMD needs vaccination, continuous monitoring, trade restrictions and isolations, or elimination of millions of animals to prevent the spread of the disease. The World Organization of Animal Health (OIE) classifies countries with the following stages with regards to FMD such as FMD present with or without vaccination, FMD free without vaccination and FMD free with vaccination. Countries classified as FMD-free without vaccination have the highest export for animal derived components; therefore these countries strive hard for maintain their current status by preventing the FMD viruses. Favorable government initiatives to prevent and restrict the FMD outbreaks have boosted the demand for FMD vaccines market. High prevalence of foot and mouth diseases in developing countries in Asia Pacific and Latin America are also assisting the steady growth of FMD vaccines market. Asia Pacific held the largest share in the global FMD vaccines market owing to the large number of cattle and dairy animals in developing countries such as India, Bangladesh, China, Hong Kong and Pakistan which as susceptible to FMD endemics. The FMD vaccines market consists of large number of local players operating in the market. Moreover, government subsidies and funding for vaccines production and consumptions have restricted the entry of large pharmaceutical companies to venture in the market.

Growing Demand for Oil-based Vaccines to Drive the Market

In 2021, conventional vaccines held the largest share in the global FMD vaccines market in terms of vaccine type. The rise in preventive vaccination programs in FMD endemic prone areas and developed countries such as U.S., Canada, and U.K. will continue to boost the market for conventional vaccines market during the forecast period. Conventional vaccines are further segmented in to aluminum hydroxide/saponin based vaccines and oil-based vaccines. The oil-based vaccines are anticipated to grow at the fastest rate during the forecast period from 2018 to 2026 owing to advantages associated with oil-based FMD such as initiation of high titers and longer antibody responses resulting in better protection. Emergency vaccines are also expected to grow at a steady rate during the forecast period owing to the growing cases of FMD in the developing region.

Asia Pacific to Lead the Foot and Mouth Disease Vaccines Market

In 2021, Asia Pacific held the largest share in the global FMD vaccines market owing to the presence of developing nations with high headcount of cattle, pigs and sheep those are susceptible for FMD viruses. Agriculture and dairy industry is one of the prime industries in countries such as India, China, Bangladesh, and Pakistan; hence, regular vaccination drives are conducted by government to prevent outbreak of FMD that would affect the dairy and agriculture industries. According to OIE the direct and indirect losses associated with FMD is approximately US$ 5 billion globally. The impact of FMD has led to the successful campaigns of disease eradication in developed regions in North America and Europe. Minimum cases of FMD in have been recorded in these regions, hence; FMD vaccines market will exhibit sluggish growth rate in the North America and Europe compared to other regions in the market.

Market is studied in order to understand the current and future market trends in the foot and mouth disease vaccines market. The market is estimated by providing the compounded annual growth rate (CAGR) and data forecast from 2018 to 2026. Strategic merger, acquisition and collaboration among the key players for developing innovative product pipeline mentioned in the business strategy section. The key players currently engaged in the foot and mouth disease market are Merck Animal Health, Brilliant Bio Pharma Ltd., Agrovet Co., Indian Immunologics Limited, Merial S.A.S, Inova Biotecnologia, Intervac (Pvt). Ltd among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Foot And Mouth Disease (FMD) Vaccines market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Foot And Mouth Disease (FMD) Vaccines market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Vaccine

  • Conventional Vaccines
    • Aluminum Hydroxide/Saponin based Vaccines
    • Oil-based Vaccine
  • Emergency Vaccines

Animal

  • Cattle
  • Sheep & Goat
  • Swine
  • Others (Deer, Antelope, Gazelle)

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Foot And Mouth Disease (FMD) Vaccines market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Foot And Mouth Disease (FMD) Vaccines market?
  • Which is the largest regional market for Foot And Mouth Disease (FMD) Vaccines market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Foot And Mouth Disease (FMD) Vaccines market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Foot And Mouth Disease (FMD) Vaccines market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Foot And Mouth Disease (FMD) Vaccines Market
  • 2.2. Global Foot And Mouth Disease (FMD) Vaccines Market, By Vaccine, 2021 (US$ Million)
  • 2.3. Global Foot And Mouth Disease (FMD) Vaccines Market, By Animal, 2021 (US$ Million)
  • 2.4. Global Foot And Mouth Disease (FMD) Vaccines Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Foot And Mouth Disease (FMD) Vaccines Market: Competitive Analysis

  • 3.1. Market Positioning of Key Foot And Mouth Disease (FMD) Vaccines Market Vendors
  • 3.2. Strategies Adopted by Foot And Mouth Disease (FMD) Vaccines Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Foot And Mouth Disease (FMD) Vaccines Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Foot And Mouth Disease (FMD) Vaccines Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Conventional Vaccines
      • 5.3.1.1. Aluminum Hydroxide/Saponin based Vaccines
      • 5.3.1.2. Oil-based Vaccine
    • 5.3.2. Emergency Vaccines

6. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Cattle
    • 6.3.2. Sheep & Goat
    • 6.3.3. Swine
    • 6.3.4. Others (Deer, Antelope, Gazelle)

7. North America Foot And Mouth Disease (FMD) Vaccines Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
  • 7.3. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
  • 7.4.Foot And Mouth Disease (FMD) Vaccines Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 7.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 7.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 7.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)

8. UK and European Union Foot And Mouth Disease (FMD) Vaccines Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
  • 8.3. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
  • 8.4.Foot And Mouth Disease (FMD) Vaccines Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 8.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 8.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 8.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 8.4.1.4.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 8.4.1.5.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 8.4.1.6.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)

9. Asia Pacific Foot And Mouth Disease (FMD) Vaccines Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
  • 9.3. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
  • 9.4.Foot And Mouth Disease (FMD) Vaccines Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 9.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 9.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 9.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 9.4.1.4.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 9.4.1.5.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 9.4.1.6.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)

10. Latin America Foot And Mouth Disease (FMD) Vaccines Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
  • 10.3. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
  • 10.4.Foot And Mouth Disease (FMD) Vaccines Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 10.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 10.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 10.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)

11. Middle East and Africa Foot And Mouth Disease (FMD) Vaccines Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
  • 11.3. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
  • 11.4.Foot And Mouth Disease (FMD) Vaccines Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 11.4.1.1.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 11.4.1.2.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Vaccine, 2020-2030, USD (Million)
        • 11.4.1.3.1. Foot And Mouth Disease (FMD) Vaccines Market: By Animal, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. India Immunological Ltd.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Merck Animal Health
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Brilliant Bio Pharma Ltd.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Agrovet Co.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Merial S.A.S
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Inova Biotecnologia
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Intervac (Pvt). Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. China Animal Husbandry Co., Ltd.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Biogenesis-Bago S.A.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Vetal Animal Health Products S.A.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives